Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
May 09, 2024 16:05 ET
|
Maravai LifeSciences Holdings LLC
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to...
Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024 16:05 ET
|
Lisata Therapeutics, Inc.
Seminal Phase 2b ASCEND trial top-line data expected in fourth quarter of 2024 Projected available cash to fund planned operations into early 2026 covering all studies through data Conference call...
U.S. Global Investors Reports Resilient Results for a Challenging March Quarter, Expands Brand in the U.K.
May 09, 2024 16:05 ET
|
U.S. Global Investors
SAN ANTONIO, May 09, 2024 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and...
Telesis Bio Reports First Quarter 2024 Financial Results
May 09, 2024 16:05 ET
|
Telesis Bio
Telesis Bio Reports First Quarter 2024 Financial Results
PLBY Group Reports First Quarter 2024 Financial Results
May 09, 2024 16:05 ET
|
PLBY Group, Inc.
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most...
Lightbridge Provides Business Update and Announces First Quarter 2024 Financial Results
May 09, 2024 16:05 ET
|
Lightbridge Corporation
Lightbridge announced its financial results for the first quarter ended March 31, 2024, and provided an update on the Company’s continued progress.
Alliance Entertainment Reports Third Quarter and Nine Month Fiscal Year 2024 Financial Results
May 09, 2024 16:05 ET
|
Alliance Entertainment
Alliance Entertainment Reports Third Quarter and Nine Month Fiscal Year 2024 Financial Results
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024 16:05 ET
|
Crinetics Pharmaceuticals, Inc.
Late-Breaking Presentations of Initial Results From Phase 2 Studies of Atumelnant (CRN04894) in Congenital Adrenal Hyperplasia and ACTH-Dependent Cushing’s Syndrome Will be Presented at ENDO...
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
May 09, 2024 16:05 ET
|
Matinas BioPharma Holdings, Inc.
Recent $10 million financing expected to fund planned development programs and operations into the second quarter of 2025 Discussions to secure a partner to advance MAT2203 into the Phase 3 ORALTO...
Upwork to Present at the Needham Technology, Media & Consumer Conference
May 09, 2024 16:03 ET
|
Upwork Inc.
Upwork CFO Erica Gessert will participate in a fireside chat at the Needham Technology, Media & Consumer Conference.